NCT Number: NCT00215306
CHARITÉ™ Artificial Disc Compared to Anterior Interbody Fusion for Treatment of Degenerative Disc Disease
The study is designed to evaluate the safety and effectiveness of the CHARITE Artificial Disc compared to anterior lumbar interbody fusion for treatment of degenerative disc disease at one level of the lumbar spine (either L4/L5 or L5/S1).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–60 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
About this study
Treatments for disc degeneration have historically included conservative modalities, such as rest, heat, electrotherapy, physical therapy, and analgesics to surgery. Currently, there are two main surgical techniques for treatment of disc degeneration: (1) nucleotomy or diskectomy, i.e., excision of part or all of the degenerated disc, which is typically performed for treatment of radicular syndrome in the case of disc herniation; and (2) spinal fusion, i.e., grafting bone between the vertebrae adjacent to the degenerated disc to eliminate articulation at the damaged segment, which is typically performed for treatment of degeneration together with instability and reduction of the intervertebral space. Rigid internal fixation may also be used to promote fusion.
The CHARITÉ Artificial Disc is designed to provide a new therapeutic option for treatment of degenerative disc disease as an alternative to spinal fusion to preserve function in the lumbar vertebral region. Each institution participating in the study was to treat the first 5 consecutive study participants with the CHARITE to as it involves a modification to the technique used for anterior fusion. Data will be collected on these "training" cases but will not be included in the comparison with the control (fusion) treatment.
Comparison: Outcomes for patients treated with the CHARITÉ Artificial Disc will be compared to outcomes for patients treated with anterior lumbar interbody fusion.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 18 to 60 years of age inclusive
- symptomatic degenerative disc disease confirmed by provocative discogram
- single level disease L4/L5 or L5/S1
- leg or back pain without nerve root compression
- VAS pain score >= 40
- Oswestry Disability Index score >= 30
- six months prior conservative treatment
- appropriate for anterior surgical approach
Exclusion criteria
- previous lumbar or thoracic fusion
- other spinal surgery at target level
- symptomatic multiple level degeneration
- non-contained or extruded nucleus pulposus
- compression or burst at L4, L5, or S1 due to trauma
- mid-sagittal stenosis < 8mm
- osteoporosis, osteopenia, or other metabolic bone disease of the spine
- spondylolisthesis > 3mm, scoliosis > 11 degrees
- facet joint arthrosis
- isthmic spondylolisthesis
- positive straight leg raise for radiculopathy
Treatment and study plan
Anterior Interbody Fusion with BAK Cage
DevicePrimary outcomes
-
Pain and Function (Oswestry Disability Index)
-
Neurologic Function
-
Major Adverse Events
-
Subsequent Surgical Interventions
Secondary outcomes
-
Adverse Events
-
Back and Leg Pain (VAS)
-
SF-36; Health Related Quality of Life
-
Disc Space Height
-
Fusion (control only)
-
Angular Range of Motion
-
Duration of Hospitalization
-
Work Status
-
Patient Satisfaction
Sponsors and collaborators
Lead sponsor
DePuy Spine
Industry
Registry information
Official study title
Clinical Investigation of the SB Charite III Intervertebral Disc Spacer.
Important dates
- Study start
- 2000
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Sep 22, 2005
- Registry last updated
- May 23, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Erector Spinae Plane Block vs Local Infiltration Following Fusion Surgery
NCT06199999
Bone Diseases, Confusion
Iowa City, Iowa, United States
View Trial DetailsStudy of the ReGelTec HYDRAFIL System
NCT04984629
Back Pain, Bone Diseases
Calgary, Alberta, Canada
View Trial DetailsA Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.
NCT04416321
Bone Diseases, Degenerative Disc Disease
Lancaster, Pennsylvania, United States
View Trial DetailsOsteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)
NCT00948532
Back Pain, Bone Diseases
La Jolla, California, United States
View Trial Details